HASTINGS PAUL J — SEC insider filings

SEC reporting owner CIK 1309702. 34 insider filings on record with FilingPulse; latest filed 2026-11-10.

Transaction summary — filings shown

Covers all 34 filings on record, filed 2021-01-12 to 2026-11-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Nkarta, Inc. (NKTX)Chief Executive Officer, Director21—18 legs · 127,852 sh · $1,593,97116
Pacira BioSciences, Inc. (PCRX)Director9—6 legs · 12,623 sh · $607,33512
enGene Therapeutics Inc. (ENGN)Director3——3
Azora Therapeutics, Inc. (DE) (AZR)Director1———

Insider filings — HASTINGS PAUL J

FiledFormIssuerReported transactionsSource
2026-11-103Azora Therapeutics, Inc. (DE) (AZR)Holdings only — no transactions reportedEDGAR
2026-06-224Nkarta, Inc. (NKTX)Sale (S): 1,776 @ $2.71EDGAR
2026-06-174enGene Therapeutics Inc. (ENGN)Grant/award (A): 31,000 (derivative) @ $0EDGAR
2026-01-204Nkarta, Inc. (NKTX)Sale (S): 26,046 @ $2.07EDGAR
2026-01-084Nkarta, Inc. (NKTX)Grant/award (A): 94,000 @ $0 · Grant/award (A): 562,000 (derivative) @ $0EDGAR
2025-06-204Nkarta, Inc. (NKTX)Sale (S): 1,790 @ $1.79EDGAR
2025-06-164enGene Holdings Inc. (ENGN)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2025-06-094Nkarta, Inc. (NKTX)Grant/award (A): 377,000 (derivative) @ $0EDGAR
2025-01-174Nkarta, Inc. (NKTX)Sale (S): 17,378 @ $2.20EDGAR
2025-01-074Nkarta, Inc. (NKTX)Grant/award (A): 94,500 @ $0 · Grant/award (A): 565,500 (derivative) @ $0EDGAR
2024-06-204Nkarta, Inc. (NKTX)Sale (S): 1,770 @ $5.60EDGAR
2024-06-184enGene Holdings Inc. (ENGN)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-06-134Pacira BioSciences, Inc. (PCRX)Grant/award (A): 5,230 @ $0 · Sale (S): 880 @ $28.38 · Grant/award (A): 12,179 (derivative) @ $0EDGAR
2024-03-054Nkarta, Inc. (NKTX)Disposition to issuer (D): 12,358 @ $13 · Disposition to issuer (D): 137,642 @ $13.33EDGAR
2024-01-184Nkarta, Inc. (NKTX)Sale (S): 9,697 @ $8.74EDGAR
2024-01-084Nkarta, Inc. (NKTX)Grant/award (A): 85,000 @ $0 · Grant/award (A): 509,500 (derivative) @ $0EDGAR
2023-06-224Nkarta, Inc. (NKTX)Sale (S): 1,704 @ $4.85EDGAR
2023-06-164Pacira BioSciences, Inc. (PCRX)Grant/award (A): 1,775 @ $0 · Grant/award (A): 12,925 (derivative) @ $0EDGAR
2023-06-074Pacira BioSciences, Inc. (PCRX)Sale (S): 580 @ $38.34EDGAR
2023-05-174Pacira BioSciences, Inc. (PCRX)Option exercise (M): 7,000 @ $29.90 · Sale (S): 7,000 @ $41.85 · Option exercise (M): 7,000 (derivative) @ $0EDGAR
2023-01-184Nkarta, Inc. (NKTX)Grant/award (A): 64,500 @ $0 · Sale (S): 3,691 @ $5.49 · Grant/award (A): 386,500 (derivative) @ $0EDGAR
2022-09-304Nkarta, Inc. (NKTX)Sale (S): 23,376 @ $13.03 · Sale (S): 498 @ $13EDGAR
2022-09-224Nkarta, Inc. (NKTX)Sale (S): 6,126 @ $13.01EDGAR
2022-07-134Pacira BioSciences, Inc. (PCRX)Sale (S): 533 @ $56.95EDGAR
2022-06-214Nkarta, Inc. (NKTX)Grant/award (A): 19,500 @ $0 · Grant/award (A): 120,000 (derivative) @ $0EDGAR
2022-06-084Pacira BioSciences, Inc. (PCRX)Grant/award (A): 1,160 @ $0 · Grant/award (A): 8,225 (derivative) @ $0EDGAR
2022-01-194Nkarta, Inc. (NKTX)Grant/award (A): 41,900 @ $0 · Grant/award (A): 251,100 (derivative) @ $0EDGAR
2021-10-014Nkarta, Inc. (NKTX)Sale (S): 8,277 @ $27.20 · Sale (S): 223 @ $26.53EDGAR
2021-06-234Nkarta, Inc. (NKTX)Sale (S): 4,693 @ $26.39 · Sale (S): 3,807 @ $26.89EDGAR
2021-06-114Pacira BioSciences, Inc. (PCRX)Grant/award (A): 1,066 @ $0 · Grant/award (A): 7,626 (derivative) @ $0EDGAR
2021-06-084Pacira BioSciences, Inc. (PCRX)Sale (S): 630 @ $62.19EDGAR
2021-04-014Nkarta, Inc. (NKTX)Sale (S): 11,461 @ $30.23 · Sale (S): 2,409 @ $31.24 · Sale (S): 3,130 @ $32.21EDGAR
2021-03-094Pacira BioSciences, Inc. (PCRX)Option exercise (M): 3,000 @ $13.98 · Sale (S): 3,000 @ $65.88 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2021-01-124Nkarta, Inc. (NKTX)Grant/award (A): 157,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1309702 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs